Larvol Delta - ABVC-BioPharma-Announces-Completion-of-Subject-Treatment-for-Interim-Analysis-on-ADHD-Phase-IIb-Clinical-Study

BLI-1008 - ABVC BioPharma

https://www.globenewswire.com/news-release/2023/12/07/2792515/0/en/ABVC-BioPharma-Announces-Completion-of-Subject-Treatment-for-Interim-Analysis-on-ADHD-Phase-IIb-Clinical-Study.html

Dec 7, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next